stella
beta
Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma. — Stella
Recruiting
Back to Nasopharyngeal Cancinoma (NPC) trials
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations
(6 sites)
China
Dongguan People's Hospital, Dongguan, Guangdong
Sun yat-sen university cancer center, Guangzhou, Guangdong
Affiliated Cancer Hospital of Shantou University Medical College, Shantou, Guangdong
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center, Shenzhen, Guangdong
The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong
Show all 6 locations
View full record on ClinicalTrials.gov